Journal profile · Computer Science, Interdisciplinary Applications

Current Computer-Aided Drug Design

ISSN 1573-4099 · eISSN 1875-6697 · Bentham Science Publishers B.V. · U ARAB EMIRATES · Quarterly · Founded 2005

Current Computer-Aided Drug Design: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.48; hybrid open access; median 87 days to acceptance (42 articles, last 24 months); community-reported acceptance: fairly easy; 37 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.48Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time87 daysMedian, submission to acceptance · 42 articles, last 24 months · Crossref
APC—No source gives fee information
AcceptanceFairly easyCommunity average
Articles per year372025 · OpenAlex count

Scope

Aims, scope and focus

Current Computer-Aided Drug Design is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Synthesis and biological activity and Diverse Scientific Research Studies, together about 50.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Aims & Scope Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, theoretical chemistry; computational chemistry; computer and molecular graphics; molecular modeling; protein engineering; drug design; expert systems; general structure-property relationships; molecular dynamics; chemical database development and usage etc., providing excellent rationales for drug development.

Source: LetPub

Research area (LetPub): Computer Science, Interdisciplinary Applications

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Computational Drug Discovery MethodsComputer Science34.7%
  2. Synthesis and biological activityChemistry10.3%
  3. Diverse Scientific Research StudiesHealth Professions5.9%
  4. Machine Learning in BioinformaticsBiochemistry, Genetics and Molecular Biology4.1%
  5. Cholinesterase and Neurodegenerative DiseasesMedicine3.4%
  6. Cancer Research and TreatmentMedicine3.4%
  7. Click Chemistry and ApplicationsChemistry2.8%
  8. vaccines and immunoinformatics approachesBiochemistry, Genetics and Molecular Biology2.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorChemistry, MedicinalZone 4
MinorComputer Science, Interdisciplinary ApplicationsZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorChemistry, MedicinalZone 4
MinorComputer Science, Interdisciplinary ApplicationsZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorChemistry, MedicinalZone 4
MinorComputer Science, Interdisciplinary ApplicationsZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.48LetPub ·
CiteScore 2026-06
2.9LetPub ·
SJR 2026-06
0.32LetPub ·
SNIP 2026-06
0.42LetPub ·
h-index
24LetPub ·
h-index
44OpenAlex ·
i10-index
292OpenAlex ·
2-year mean citedness
1.54OpenAlex ·
Self-citation rate
6.7%LetPub ·
Share of gold OA articles
8.75%LetPub ·

Volume

Articles per year
55LetPub ·

Articles by year OpenAlex count · 1,051 in total · the current year is incomplete

YearArticlesOpen accessCitations
20266013
202537036
20248114236
202311112515
2022524276
2021252108

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

87 daysMedian, submission to acceptance · P25–P75 67 days – 112 days

Acceptance to online
median 126 days (42 articles)
Submission to online
median 211 days
Sample
42 articles with submission and acceptance dates (231 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Bentham Science Publishers B.V.
Country or region
U ARAB EMIRATES
Language
English
Frequency
Quarterly
Founded
2005
ISSN
1573-4099
Electronic ISSN
1875-6697
Official links

FAQ

Frequently asked questions about Current Computer-Aided Drug Design

What CAS zone is Current Computer-Aided Drug Design in?

In the 2025 upgraded edition of the CAS Journal Ranking, Current Computer-Aided Drug Design is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal / Computer Science, Interdisciplinary Applications. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Current Computer-Aided Drug Design?

The latest impact factor listed by LetPub is 1.48; CiteScore 2.9, h-index 44.

How long does peer review take at Current Computer-Aided Drug Design?

Based on the dates recorded on 42 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 67–112 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Current Computer-Aided Drug Design?

According to LetPub and DOAJ records, Current Computer-Aided Drug Design is indexed in SCIE and Scopus.

Is Current Computer-Aided Drug Design open access, and what is the APC?

Current Computer-Aided Drug Design is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .